Leading medical diagnostics/research company announces the availability of
seven new monoclonal CEACAM antibodies
DEDHAM, Mass., May 24 /PRNewswire/ -- Signet Laboratories, Inc., a
leading medical diagnostics/research company specializing in the
development of monoclonal antibodies and diagnostic assays for cancer,
infectious disease, and neurodegenerative disease, today announced the
availability of seven new monoclonal CEACAM antibodies.
CEA related cell adhesion molecules (CEACAM) are members of the
carcinoembryonic antigen (CEA) family. The CEA family contains seven CEACAM
and 11 pregnancy specific glycoproteins (PSG1-PSG11).
CEACAM is differentially expressed in leucocytes and epithelial cells,
and certain CEA related cell adhesion molecules are upregulated in a
variety of adenocarcimomas.
Signet will be offering the following CEACAM antibodies:
CEACAM6 Clone 9A6
CEACAM5 Clone 26/3/13
CEACAM5 Clone 26/5/1
CEACAM1, 3, 4, 5, 6 Clone D14HD11
CEACAM5, 6 Clone MUS
CEACAM1, 5, 6, 8 Clone TET2
CEACAM1 Clone GM8G5
The Signet CEACAM panel of monoclonal antibodies offers investigators a
valuable tool for cancer research.
CEACAM complements Signet's current cancer and cell cycle product
portfolio, which includes markers such as Cyclin D1, Cyclin E, HE4 and
Hepsin.
About Signet Laboratories, Inc.
Signet Laboratories, Inc. (Signet, Dedham, MA) is a leading medical
diagnostics/research company specializing in the development of monoclonal
antibodies and diagnostic assays for cancer, infectious disease, and
neurodegenerative disease. Signet was created in 1989 as a commercial
spinout of Johnson & Johnson's Cambridge Research Laboratories, Inc. (CRL,
Cambridge, MA).
The Company was founded to continue the mission originally established at
CRL -- the early detection and recurrence monitoring of patients with cancer
and infectious disease. Signet has developed patented technology for diagnosis
and recurrence monitoring and for risk assessment of asymptomatic patients in
these areas. For more than a decade, the Company has aggressively maintained
licensing and development programs, which are responsible for its broad patent
and intellectual estate.
Contact Information
Company Contact Immunohistochemistry Contact
Colleen Scott Angela Thomas
Signet Laboratories, Inc. Signet Laboratories, Inc.
180 Rustcraft Road 180 Rustcraft Road
Dedham, MA 02026 Dedham, MA 02026
Phone: 781.915.1404 Phone: 781.915.1417
Fax: 781.461.2456 Fax: 781.461.2456
cscott@signetlabs.com athomas@signetlabs.com
SOURCE Signet Laboratories, Inc.
 back to top
Related links:
http://www.signetlabs.com/
CONTACT:
Colleen Scott, +1-781-915-1404,
cscott@signetlabs.com, or Angela Thomas, +1-781-915-1417,
athomas@signetlabs.com, both Signet Laboratories, Inc.
|
